Table 1 Priority pediatric ARV formulations
Pediatric ARV Dosage Form | 2007 WHO Recommendation | Ideal Dosage Form | Produced and purchased | 2009 WHO Recommendation |
|---|---|---|---|---|
3TC30/NVP50/ZDV60 | Urgent | yes | yes | yes |
3TC30/NVP60/ZDV60 | Urgent | Â | Â | Â |
3TC75/NVP100/ZDV150 | Urgent | Â | Â | Â |
3TC30/ZDV60 | Urgent | yes | yes | yes |
3TC75/ZDV150 | Urgent | Â | Â | Â |
3TC30/d4T6 | Urgent | yes | yes | yes |
3TC75/d4T15 | Urgent | Â | Â | Â |
3TC30/NVP50/d4T6 | Urgent | yes | yes | yes |
3TC20/NVP35/d4T5 | Urgent | Â | yes | Â |
3TC30/NVP50/d4T7 | Urgent | Â | Â | Â |
3TC60/NVP100/d4T12 | Urgent | Â | yes | Â |
3TC40/NVP70/d4T10 | Urgent | Â | yes | Â |
NVP 50 | Urgent | yes | Â | yes |
NVP 100 | Urgent | Â | Â | Â |
LPV100/r25 | Urgent | yes | yes | yes |
LPV90/r22.5 | Urgent | Â | Â | Â |
ABC 60 | Urgent | yes | yes | yes |
ABC 120 | Urgent | Â | Â | Â |
ABC 150 | Urgent | Â | Â | Â |
EFV 100 | High | yes | yes | yes |
EFV 600 | High | Â | yes | Â |
ABC60/3TC30 | High | yes | yes | yes |
ABC150/3TC75 | High | Â | Â | Â |
ZDV 60 | High | yes | Â | yes |
ZDV 100 | High | Â | yes | Â |
ABC60/3TC30/ZDV60 | High | yes | Â | yes |
ABC150/3TC75/ZDV150 | High | Â | Â | Â |
d4T 6 | High | yes | Â | yes |
d4T 15 | High | Â | Â | Â |
ddI 125 | Important | Â | yes | Â |
ddI 200 | Important | Â | yes | Â |
3TC 30 | Important | yes | Â | yes |
3TC 75 | Important | Â | Â | Â |
3TC 150 | Important | Â | yes | Â |
EFV100/FTC35 | Important | yes | Â | yes |
FTC 35 | Important | yes | Â | yes |
RTV 25 | Important | yes | Â | yes |
RTV 100 | Important | Â | Â | Â |
FPV* | Important | yes | Â | yes |
DRV* | Important | Â | Â | Â |
ABC60/NVP50/ZDV60 | Â | Â | Â | yes |
ATV* | Â | Â | Â | yes |